Sarveshwar Foods Limited has scheduled a Board of Directors meeting for September 5, 2026, to consider proposals for raising funds through equity shares or convertible instruments. The agenda also includes the adoption of the company’s Employee Stock Option Scheme 2026.

The meeting aims to approve potential capital raising methods such as preferential allotment, right issues, Qualified Institutional Placements (QIPs), American Depositary Receipts (ADRs), Global Depository Receipts (GDRs), or Foreign Currency Convertible Bonds (FCCBs). These instruments may be issued in one or more tranches.

Agenda Details

The Board will deliberate on two primary items:

• Fund Raising: Approval of issuing equity shares, convertible instruments, or other securities via methods including preferential allotment, right issues, QIPs, ADRs, GDRs, or FCCBs.
• ESOP Adoption: Introduction of the Sarveshwar Foods Limited Employee Stock Option Scheme 2026, subject to SEBI regulations and shareholder approval.

The Board may also consider other matters with the Chair’s permission.

Trading Window Closure

Pursuant to SEBI’s Prohibition of Insider Trading Regulations, 2015, the trading window for dealing in the company’s securities will remain closed from September 2, 2026. The window will reopen 48 hours after the conclusion of the Board meeting and the declaration of its outcome.

This disclosure is made in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Sarveshwar Foods reported a consolidated net profit after tax (PAT) of ₹8.22 crore for the quarter ended June 30, 2026 (Q1FY27), marking a 17.04% year-on-year increase from ₹7.02 crore in Q1FY26. The growth was primarily fueled by an 18.81% surge in revenue from operations, which rose to ₹358.03 crore from ₹301.35 crore in the corresponding period of the previous fiscal year. This performance underscores the company’s resilience amidst global economic uncertainties, with management citing robust order pipelines and sustained brand trust as key drivers for the top-line expansion.

The results were filed with the National Stock Exchange of India Limited and BSE Limited on July 31, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sadhvi Sharma, Company Secretary and Compliance Officer, signed off on the submission. The company highlighted that its operational strength is supported by ISO 22000:2018 and USFDA certifications, along with BRC, Kosher, and NOP-USDA Organic accreditations, reinforcing its competitive edge in premium food exports.

Financial Performance Breakdown

While revenue and profit figures showed significant growth, EBITDA remained relatively flat, increasing marginally by 1.07% to ₹17.31 crore from ₹17.13 crore in Q1FY26. Consequently, the EBITDA margin contracted slightly to 4.83% from 5.68% in the prior year. Profit before tax (PBT) saw a stronger jump of 15.81%, rising to ₹10.82 crore from ₹9.34 crore. The PAT margin also experienced a minor compression, settling at 2.29% compared to 2.33% in Q1FY26.

Management Commentary

Anil Kumar, Managing Director of Sarveshwar Group, attributed the positive results to the effectiveness of the company’s long-term strategy and operational discipline. He noted that increasing demand for premium-quality rice, organic products, and value-added food offerings across both domestic and international markets has strengthened their market position. The company emphasized its focus on improving operational efficiencies, strengthening supply-chain resilience, and expanding its distribution network. Investments in technology, brand development, and sustainable farming practices were cited as critical components supporting long-term value creation.

What the Numbers Show

The divergence between revenue growth and EBITDA expansion warrants attention. While top-line revenue surged by nearly 19%, operating profit (EBITDA) grew by only 1.07%. This suggests that cost structures or input prices may have risen disproportionately to sales volume during the quarter, leading to a compression in EBITDA margins from 5.68% to 4.83%. However, the bottom line (PAT) grew faster than EBITDA, indicating potential benefits from other income or tax efficiencies not detailed in the headline metrics. Investors should monitor whether this margin pressure persists as the company scales its export presence and invests in brand development.